Skip to content

Author

Daichi Shigemizu

4 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Alzheimer's disease genetics converges on microglial and neuronal dysregulation.

Alzheimer's disease (AD) is the most common cause of dementia, with global case numbers projected to reach 153 million in 20501. AD is highly heritable, with twin-based heritability estimates of 60-80%2. Although 1,200 causal loci are predicted to exist for AD3, approximately 80 loci have been associated with AD in two...

E. Uffelmann, D. Wightman, S. Bahrami et al. · 0 citations
#protein folding Open access Oct 2026

Integration of blood‐based biomarkers and genomic variants identifies individuals with mild cognitive impairment who benefit from multidomain intervention

The findings suggest that BBMs, potentially in combination with genetic information, may help identify individuals with a more progressive AD‐related biological profile who may derive greater benefit from multidomain intervention.

Tetsuaki Kimura, A. Nakamura, T. Sugimoto et al. · 0 citations
Open access Sep 2026

Validation and refinement of a biomarker panel for frailty assessment and prediction of muscle weakness in older adults

Frailty is a complex geriatric syndrome characterized by age-related declines in physiological function and cognitive reserve. To promote early prevention and intervention, minimally invasive and objective biomarkers that can detect frailty progression are required. We aimed to identify biomarkers associated with frail...

Akiko Yamakawa, Tohru Hosoyama, M. Takemura et al. · 0 citations
Open access Sep 2026

Genetic Insights Into Protective Effects of GLP-1 Receptor Agonists on Stroke and Alzheimer Disease Across Ancestries

Background and Objectives Stroke and dementia are leading causes of death and disability worldwide, requiring enhanced preventive strategies. Glucagon-like peptide-1 receptor agonists (GLP-1RA), widely used for type 2 diabetes (T2D) and obesity, have demonstrated pleiotropic effects, including cardiovascular benefits,...

Ilana Caro-Châtelier, M. Sargurupremraj, Cheng-Ran Yang et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.